Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Return on Sales: 2009-2025

Historic Return on Sales for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -0.30%.

  • Lifecore Biomedical's Return on Sales fell 32.00% to -0.30% in Q2 2025 from the same period last year, while for May 2025 it was -0.30%, marking a year-over-year decrease of 32.00%. This contributed to the annual value of -0.30% for FY2025, which is 32.00% down from last year.
  • Latest data reveals that Lifecore Biomedical reported Return on Sales of -0.30% as of FY2025, which was down 1,536.80% from 0.02% recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Return on Sales registered a high of 0.02% during FY2024, and its lowest value of -0.92% during FY2022.
  • Its 3-year average for Return on Sales is -0.21%, with a median of -0.30% in 2025.
  • Per our database at Business Quant, Lifecore Biomedical's Return on Sales crashed by 81bps in 2022 and then surged by 57bps in 2023.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Return on Sales stood at -0.10% in 2021, then tumbled by 81bps to -0.92% in 2022, then soared by 57bps to -0.34% in 2023, then skyrocketed by 36bps to 0.02% in 2024, then plummeted by 32bps to -0.30% in 2025.